Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6114103 | Transfusion and Apheresis Science | 2014 | 9 Pages |
Abstract
Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Sergio Rutella, Caterina Giovanna Valentini, Stefano Ceccarelli, Maria Teresa Romano, Letizia P. Brescia, Giuseppe Maria Milano, Franco Locatelli,